As of 2025-04-30, the Relative Valuation of Medicenna Therapeutics Corp (MDNA.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.08 CAD, the upside of Medicenna Therapeutics Corp based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-04-25 | -3.14 |
| 2025-04-24 | -3.05 |
| 2025-04-23 | -3.02 |
| 2025-04-22 | -3.05 |
| 2025-04-21 | -3.08 |
| 2025-04-17 | -3.20 |
| 2025-04-16 | -2.91 |
| 2025-04-15 | -2.85 |
| 2025-04-14 | -2.76 |
| 2025-04-11 | -2.62 |
| 2025-04-10 | -2.62 |
| 2025-04-09 | -2.70 |
| 2025-04-08 | -2.47 |
| 2025-04-07 | -2.70 |
| 2025-04-04 | -2.62 |
| 2025-04-03 | -2.70 |
| 2025-04-02 | -2.88 |
| 2025-04-01 | -2.82 |
| 2025-03-31 | -2.85 |
| 2025-03-28 | -2.85 |
| 2025-03-27 | -2.91 |
| 2025-03-26 | -2.91 |
| 2025-03-25 | -2.88 |
| 2025-03-24 | -2.88 |
| 2025-03-21 | -2.91 |
| 2025-03-20 | -2.91 |
| 2025-03-19 | -2.91 |
| 2025-03-18 | -2.88 |
| 2025-03-17 | -3.08 |
| 2025-03-14 | -3.20 |
| 2025-03-13 | -3.17 |
| 2025-03-12 | -3.14 |
| 2025-03-11 | -3.08 |
| 2025-03-10 | -2.94 |
| 2025-03-07 | -2.88 |
| 2025-03-06 | -2.88 |
| 2025-03-05 | -3.00 |
| 2025-03-04 | -2.73 |
| 2025-03-03 | -2.68 |
| 2025-02-28 | -3.02 |
| 2025-02-27 | -2.94 |
| 2025-02-26 | -3.11 |
| 2025-02-25 | -3.20 |
| 2025-02-24 | -3.29 |
| 2025-02-21 | -3.34 |
| 2025-02-20 | -3.49 |
| 2025-02-19 | -3.58 |
| 2025-02-18 | -3.69 |
| 2025-02-14 | -3.90 |
| 2025-02-13 | -3.84 |